Photo taken from Paulo G. Bergerot/X
Sep 7, 2024, 06:16
Paulo Bergerot on a Remote Exercise Program for lung cancer patients on ICI’s at WCLC24 – Florez Lab
Florez Lab shared on X:
“Dr. Paulo Bergerot will present his research on a Remote Exercise Program for lung cancer patients on immune checkpoint inhibitors at WCLC24.
This innovative study is poised to change the way we approach patient care. Stay tuned for updates!”
Source: Florez Lab/X
More posts featuring WCLC24 on oncodaily.com
Paulo G. Bergerot, MD, is a medical oncologist and post-doctoral fellow at the Department of Medical Oncology at City of Hope Comprehensive Cancer Center in California, USA. His research interests include genomics, psycho-oncology, personalized medicine, shared decision making, and clinical oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 08:13
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07